A collaborative network of European and North American scientists, including from the University of North Carolina at Chapel Hill School of Medicine, have been awarded a total of $6 million over five years to explore the biology of heart failure and to find new therapies for it.
This is the first study to demonstrate active replication of HIV virus in a cell type other than immune T cells and which may help to predict patients at greatest risk for HIV dementia.
Cam Patterson, MD, MBA, division chief of cardiology at the University of North Carolina at Chapel Hill School of Medicine, has been named the recipient of the 2012 North America Vascular Biology Association Judah Folkman Award in Vascular Biology.
Patients with high-risk non-melanoma skin carcinomas of the head and neck may benefit from concomitant radiotherapy and chemotherapy, according to a UNC-led study.
A project to improve the receipt of beneficial supportive care services for younger women who have breast cancer has received a grant of more than $780,000 from the Centers for Disease Control and Prevention.
Carolina Advanced Health will care for 5,000 BCBSNC members with chronic conditions. Former Brown University School of Medicine clinical professor, Dr. Thomas K. Warcup, will lead this first-of-its kind practice as medical director.
Burks named new Chair of UNC Department of Pediatrics, Physician-in-Chief of N.C. Children's Hospital
Wesley Burks, MD, will join the UNC School of Medicine on Dec. 1, 2011. He is an internationally-renowned expert in pediatric allergy.
Dr. Nicholas Shaheen, professor in the UNC School of Medicine, adjunct professor in the UNC Gillings School of Global Public Health and director of the UNC Center for Esophageal Diseases and Swallowing, will co-direct Barrett’s Esophagus Translational Research Network (BETRNet) projects.
University of North Carolina at Chapel Hill scientists investigate a gene that appears to protect against rheumatoid arthritis. The research could inform future treatment approaches.
If one of your legs is shorter than the other, that may increase your risk of pain in your knees or hips, some researchers suspect. UNC’s Yvonne Golightly, PT, PhD, explains what researchers do and don’t know about this surprisingly common condition.
A 36-year-old Anson County man donates his own stem cells for a transplant to tame an exceptionally rare condition.
Malaria vaccine candidate, RTS,S reduces the risk of malaria by half in African children aged 5 to 17 months
The University of North Carolina at Chapel Hill enrolled 1,600 children at the study site in Lilongwe, Malawi.
David R. Rubinow, MD, Assad Meymandi Distinguished Professor and Chair of Psychiatry, is among the 65 new members announced by the institute on Monday (Oct. 17).
Elizabeth Swaringen, who writes our Family House Diaries stories, shares additional insights about the man who is featured in the latest installment.
African Americans were also more likely to have knee osteoarthritis, but less likely to be affected by hand osteoarthritis than Caucasians, according to new findings from UNC's long-running Johnston County Osteoarthritis Project.
New research from the University of North Carolina at Chapel Hill shows that obesity may make annual flu shots less effective. Three UNC School of Medicine faculty are co-authors of the study.
Study suggests that restricting sunbathing or visits to the tanning booth to morning hours would reduce the risk of skin cancer. That’s when DNA repair of UV radiation damage may run in high gear.
News of the renewal funding arrived as the UNC researchers who run the Johnston County Osteoarthritis Project are preparing to celebrate its 20th anniversary on Saturday, Oct. 29, in Smithfield, N.C.
The finding provides clarity to a hotly debated topic in science and provides biologists with more information to interpret experiments involving genetic measurements in males and females.
UNC surgical oncologist co-authors Lancet editorial
Melissa Troester, PhD, MPH, received $150,000 to support a research project with the goal of identifying biomarkers that will help doctors understand who is at highest risk for breast cancer recurrence.
UNC scientists report what they believe is the first pre-clinical demonstration of the potential of molecularly targeted nanoparticles as a promising new class of agents that can improve chemoradiotherapy treatment.
Findings guide future research on chemotherapy resistance